Abstract
The mammalian pathogen Bordetella bronchiseptica was grown under controlled batch conditions with glutamate as the primary carbon and nitrogen source. First, a Box-Behnken statistical design quantified the effect of Mg, sulfate, and nicotinate on the antigen filamentous hemagglutinin (FHA) formation. Using lactic acid as a secondary carbon source for pH control, Mg, and SO4 each negatively affected antigen expression, while nicotinate positively affected antigen expression. Sulfate had a stronger negative effect than Mg with 10 mM eliminating FHA altogether; the highest FHA expression (about 1,000 ng/mL) occurred when either Mg concentration or SO4 concentration, but not both, was about 0.1 mM. Using two Mg and SO4 compositions modeled to yield the greatest antigen expression, three other organic acids were compared as the secondary carbon source: acetate, citrate, and succinate. Mixtures of acetate and glutamate resulted in the greatest organic acid consumption, OD, and FHA concentration (about 1,500 ng/mL), although significant acetate accumulated during these batch processes. The mechanism leading to elevated FHA expression when acetate is the secondary carbon source is unknown, particularly since these cultures were most prone to phase shift to Bvg− cultures.
This is a preview of subscription content, access via your institution.





Abbreviations
- AG:
-
Cultivations which contained acetate and glutamate as the carbon sources
- Bvg:
-
Bordetella virulence gene regulon
- CDM:
-
Chemically defined medium
- CG:
-
Cultivations which contained citrate and glutamate as the carbon sources
- DO:
-
Dissolved oxygen concentration as a percent of saturation
- FHA:
-
Adhesin filamentous hemagglutinin
- L, M, H:
-
Low, medium, and high concentrations of medium components studied
- LG:
-
Cultivations which contained lactate and glutamate as the carbon sources
- OD:
-
Optical density, a measurement of cell density and growth
- SG:
-
Cultivations which contained succinate and glutamate as the carbon sources
References
Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, Holden MT, Churcher CM, Bentley SD, Mungall KL, Cerdeno-Tarraga AM, Temple L, James K, Harris B, Quail MA, Achtman M, Atkin R, Baker S, Basham J, Bason D, Cherevach N, Chillingworth I, Collins T, Cronin M, Davis A, Doggett P, Feltwell T, Goble A, Hamlin N, Hauser H, Holroyd S, Jagels K, Leather S, Moule S, Norberczak H, O’Neil S, Ormond D, Price C, Rabbinowitsch E, Rutter S, Sanders M, Saunders D, Seeger K, Sharp S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Unwin L, Whitehead S, Barrell BG, Maskell DJ (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35:32–40
Armstrong SK, Gross R (2007) In: Locht C (ed) Bordetella: molecular microbiology. Horizon Bioscience, Wymondham, pp 165–190
Goodnow RA (1980) Biology of Bordetella bronchiseptica. Microbiol Rev 44:722–738
Carbone M, Fera MT, Pennisi MG, Masucci M, De Sarro A, Macri C (1999) Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica. Intl J Antimicrob Agents 12:355–358
Lacey BW (1960) Antigenic modulation of Bordetella pertussis. J Hyg 58:57–93
Stibitz S (2007) In: Locht C (ed) Bordetella: molecular microbiology. Horizon Bioscience, Wymondham, pp 47–68
Cotter PA, Miller JF (1997) A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of bvg-regulated antigens. Mol Microbiol 24:671–685
Cotter PA, Miller JF (1994) BvgAS-mediated signal transduction: analysis of phase locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun 62:3381–3390
Stockbauer KE, Fuchslocher B, Miller JF, Cotter PA (2001) Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol Microbiol 39:65–78
Yuk MH, Harvill ET, Miller JF (1998) The bvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol 28:945–959
Cotter PA, Miller JF (2000) Genetic analysis of the Bordetella infectious cycle. Immunopharmacol 48:253–255
Preston A, Maxim E, Toland E, Pishko EJ, Harvill ET, Caroff M, Maskell DJ (2003) Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol 48:725–736
Akerley BJ, Monack DM, Falkow S, Miller JF (1992) The bvgAS locus negatively controls motility and the synthesis of flagella in Bordetella bronchiseptica. J Bacteriol 174:980–990
Akerley BJ, Miller JF (1993) Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol 175:3468–3479
Mishra M, Deora R (2005) Mode of action of the Bordetella BvgA protein: transcriptional activation and repression of the Bordetella bronchiseptica bipA promoter. J Bacteriol 187:6290–6299
Smith AM, Guzmán CA, Walker MJ (2001) The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol Rev 25:309–333
Jacob-Dubuisson F, Locht C (2007) In: Locht C (ed) Bordetella: molecular microbiology. Horizon Bioscience, Wymondham, pp 69–96
Cotter PA, Yuk MH, Mattoo S, Akerley BJ, Boschwitz J, Relman DA, Miller JF (1998) Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect Immun 66:5921–5929
Plotkin BJ, Bemis DA (1998) Carbon source utilisation by Bordetella bronchiseptica. J Med Microbiol 47:761–765
Thalen M, van den Ijssel J, Jiskoot W, Zomer B, Roholl P, de Gooijer C, Beuvery C, Tramper J (1999) Rational medium design for Bordetella pertussis: basic metabolism. J Biotechnol 75:147–159
Frohlich BT, De Bernardez Clark ER, Siber GR, Swartz RW (1995) Improved pertussis toxin production by Bordetella pertussis through adjusting the growth medium’s ionic composition. J Biotechnol 39:205–219
Fuchs G (1999) In: Lengeler JW, Drews G, Schlegel HG (eds) Biology of Prokaryotes. Blackwell Science, New York, pp 110–162
Neidhardt FC, Ingraham JL, Schaechter M (1990) Physiology of the Bacterial Cell. Sinauer Associates, Inc., Sunderland
Stainer DW, Scholte MJ (1971) A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol 63:211–220
Jebb WHH, Tomlinson AH (1955) The nutritional requirements of Haemophilus pertussis. J Gen Microbiol 13:1–8
Fuchs G, Kröger A (1999) In: Lengeler JW, Drews G, Schlegel HG (eds) Biology of prokaryotes. Blackwell Science, New York, pp 88–109
Thalen M, Venema M, van den Ijssel J, Berwald L, Beuvery C, Martens D, Tramper J (2006) Effect of relevant culture parameters on pertussis toxin expression by Bordetella pertussis. Biologicals 34:213–220
Salyers AA, Whitt DD (2002) Bacterial pathogenesis: a molecular approach. ASM Press, Washington
Imaizumi A, Suzuki Y, Ono S, Sato H, Sato Y (1983) Effect of heptakis(2,6-O-dimethyl)β-cyclodextrin on the production of pertussis toxin by Bordetella pertussis. Infect Immun 41:1138–1143
Eiteman MA, Chastain MJ (1997) Optimization of the ion-exchange analysis of organic acids from fermentation. Anal Chim Acta 338:69–75
Licari P, Siber GR, Swartz R (1991) Production of cell mass and pertussis toxin by Bordetella pertussis. J Biotechnol 20:117–130
van de Waterbeemd B, Streefland M, Pennings J, van der Pol L, Beuvery C, Tramper J, Martens D (2009) Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production. Biotechnol Bioeng 103:900–908
Nakamura MM, Liew SY, Cummings CA, Brinig MM, Dieterich C, Relman DA (2006) Growth phase- and nutrient limitation-associated transcript abundance regulation in Bordetella pertussis. Infect Immun 74:5537–5548
Peppler MS, Judd RC, Munoz JJ (1985) Effect of proteolytic enzymes, storage and reduction on the structure and biological activity of pertussis igen, a toxin from Bordetella pertussis. Dev Biol Stand 61:75–87
Thalen M, Venema M, Dekker A, Berwald L, van den Ijssel J, Zomer B, Beuvery C, Martens D, Tramper J (2006) Fed-batch cultivation of Bordetella pertussis: metabolism and pertussis toxin production. Biologicals 34:289–297
Ezzel JW, Dobrogosz WJ, Kloos WE, Manclark CR (1981) Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios 31:171–181
Bock A, Gross R (2002) The unorthodox histidine BvgS and EvgS are responsive to the oxidation status of a quinone electron carrier. Eur J Biochem 269:3479–3484
Beier D, Deppisch H, Gross R (1996) Conserved sequence motifs in the unorthodox BvgS two-component sensor protein of Bordetella pertussis. Mol Gen Genet 252:169–176
Acknowledgments
The authors thank Sarah Lee for analytical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guetter, S.D., Eiteman, M.A. Production of biomass and filamentous hemagglutinin by Bordetella bronchiseptica . Bioprocess Biosyst Eng 37, 115–123 (2014). https://doi.org/10.1007/s00449-013-0977-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00449-013-0977-4